Decreased SLIM1 Expression and Increased Gelsolin Expression in Failing Human Hearts Measured by High-Density Oligonucleotide Arrays
Authors:
- Christine S. MoravecCMChristine S. Moravec
- Mark A. SussmanMark A. Sussman
- Nicholas R. DiPaolaNDNicholas R. DiPaola
- Dechen FuDFDechen Fu
- Lesley HawthornLHLesley Hawthorn
- Christina A. MitchellCMChristina A. Mitchell
- James B. YoungJYJames B. Young
- Gary S. FrancisGFGary S. Francis
- Patrick M. McCarthyPMPatrick M. McCarthy
- Meredith BondMBMeredith Bond
- 19 December 2000
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 102 (25) , 3046-3052
Abstract
Background —Failing human hearts are characterized by altered cytoskeletal and myofibrillar organization, impaired signal transduction, abnormal protein turnover, and impaired energy metabolism. Thus, expression of multiple classes of genes is likely to be altered in human heart failure. Methods and Results —We used high-density oligonucleotide arrays to explore changes in expression of ≈7000 genes in 2 nonfailing and 2 failing human hearts with diagnoses of end-stage ischemic and dilated cardiomyopathy, respectively. We report altered expression of (1) cytoskeletal and myofibrillar genes (striated muscle LIM protein-1 [SLIM1], myomesin, nonsarcomeric myosin regulatory light chain-2 [MLC 2 ], and β-actin); (2) genes responsible for degradation and disassembly of myocardial proteins (α 1 -antichymotrypsin, ubiquitin, and gelsolin); (3) genes involved in metabolism (ATP synthase α-subunit, succinate dehydrogenase flavoprotein [SDH Fp] subunit, aldose reductase, and TIM17 preprotein translocase); (4) genes responsible for protein synthesis (elongation factor-2 [EF-2], eukaryotic initiation factor-4AII, and transcription factor homologue-HBZ17); and (5) genes encoding stress proteins (αB-crystallin and μ-crystallin). In 5 additional failing hearts and 4 additional nonfailing controls, we then compared expression of proteins encoded by the differentially expressed genes, αB-crystallin, SLIM1, gelsolin, α 1 -antichymotrypsin, and ubiquitin. In each case, changes in protein expression were consistent with changes in transcript measured by microarray analysis. Gelsolin protein expression was also increased in cardiomyopathic hearts from tropomodulin-overexpressing (TOT) mice and rac1-expressing (racET) mice. Conclusions —Altered expression of the genes identified in this study may contribute to development of the heart failure phenotype and/or represent compensatory mechanisms to sustain cardiac function in failing human hearts.Keywords
This publication has 16 references indexed in Scilit:
- The Cardiac Expression of Striated Muscle LIM Protein 1 (SLIM1) is Restricted to the Outflow Tract of the Developing HeartJournal of Molecular and Cellular Cardiology, 1999
- The Human Phospholamban Gene: Structure and ExpressionJournal of Molecular and Cellular Cardiology, 1999
- High density synthetic oligonucleotide arraysNature Genetics, 1999
- Cardiac protein abnormalities in dilated cardiomyopathy detected by two‐dimensional polyacrylamide gel electrophoresisElectrophoresis, 1998
- A-kinase Anchoring Protein 100 (AKAP100) is Localized in Multiple Subcellular Compartments in the Adult Rat HeartJournal of Cell Biology, 1998
- Myofibril degeneration caused by tropomodulin overexpression leads to dilated cardiomyopathy in juvenile mice.Journal of Clinical Investigation, 1998
- Genome-wide expression monitoring in Saccharomyces cerevisiaeNature Biotechnology, 1997
- Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium.Journal of Clinical Investigation, 1997
- Expression of dihydropyridine receptor (Ca2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure.Journal of Clinical Investigation, 1992
- Pieces in the actin-severing protein puzzleCell, 1988